LGND - Volume dana dhuwit perusahaan Ligand Pharmaceuticals Incorporated

Logo perusahaan publik ligand.com (LGND)

Ligand Pharmaceuticals (LGND) minimizes capital expenditures by outsourcing production and testing to third-party contractors. Current cash levels illustrate the financial resilience of this strategy, where 0.45 determines this specific parameter level. The company's revenues are based on royalties from the Captisol platform, while capital stability is ensured by OmniAb technologies, which eliminate operational risks during the development of new drugs.

Ligand Pharma - Sisa dhuwit perusahaan LGND (periode 04.07.2022 - 21.11.2026)

Rincian metrik keuangan lan pasar Ligand (LGND)

- nilai saham lan prakiraan konsensus rega:
Analisis komprehensif perusahaan:LGND Ligand Pharmaceuticals
Produk merek ligand.com

For the biopharmaceutical business of Ligand Pharmaceuticals (LGND), with its focus on high-tech R&D and AI screening, liquidity is critical to ensuring the continuity of innovation. By analyzing the organization's cash balances, an investor assesses the balance between financial autonomy during inflationary periods and capital efficiency, where excess cash may indicate underinvestment in growth, thereby defining the risk profile of this security.

Pesaing langsung

Dana dhuwit perusahaan Haleon (HLN)|Volume dana dhuwit perusahaan Kenvue Inc. (KVUE)|Volume dana dhuwit perusahaan VRNA (veronapharma.com)|Sisa dhuwit perusahaan MENS|AMRX: Dhuwit awis perusahaan|Cadangan dhuwit perusahaan Perrigo Company plc|ALVO: Volume dana dhuwit perusahaan|Liquidia (LQDA) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Galapagos N.V.|Dhuwit awis perusahaan ANI Pharmaceuticals, Inc. (ANIP)|Volume dana dhuwit perusahaan MNKD|AMPH (Amphastar Corp) - Sisa dhuwit perusahaan|Dana dhuwit perusahaan pacira.com PCRX|SPRY - Dhuwit awis perusahaan|Theravance Biopharma, Inc. - Volume dana dhuwit perusahaan|Sisa dhuwit perusahaan AQST (Aquestive Therapeutics, Inc.)|SCPH: Volume dana dhuwit perusahaan|Tectonic Therapeutic Inc. - Sisa dhuwit perusahaan|TNXP (Tonix Pharma) - Volume dana dhuwit perusahaan|SXTC: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan EPRX|BHST - Cadangan dhuwit perusahaan|eXoZymes - Dhuwit awis perusahaan|Volume dana dhuwit perusahaan oramed.com ORMP|ENTX - Dana dhuwit perusahaan|Aset likuid perusahaan MindWalk Holdings HYFT|ABVC: Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Cumberland Pharmaceuticals Inc.|Dana dhuwit perusahaan Quantum BioPharma Limited|FGEN: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan TELO|Rani Therapeutics Holdings, Inc. - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan Synergy CHC Corp. SNYR|Sisa dhuwit perusahaan RLYB|LEXX: Dhuwit awis perusahaan|Sisa dhuwit perusahaan PULM (Pulmatrix Corporation)|Pheton Holdings Limited (PTHL) - Dana dhuwit perusahaan|Dhuwit awis perusahaan Aptorum|Dhuwit awis perusahaan LYRA|Impact BioMedical Inc - Total volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan TNFA|YCBD - Cadangan dhuwit perusahaan|PainReform Ltd. - Dhuwit awis perusahaan|CYTO (Auris Medical) - Total volume dana dhuwit perusahaan|LIPO - Dana dhuwit perusahaan|Sisa dhuwit perusahaan OPTN (OptiNose)|PIRS: Volume dana dhuwit perusahaan|Procaps Group S.A. (PROC) - Volume dana dhuwit perusahaan|PTPI (Petros Pharma) - Volume dana dhuwit perusahaan|QLI: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SLRN|TFFP (TFF Pharmaceuticals Inc.) - Sisa dhuwit perusahaan